Psilocybin Research Breakthroughs
Exciting research highlights the potential of psilocybin in treating major and intractable depression, particularly following its breakthrough status by the FDA. Pioneering researchers have laid the groundwork for clinical trials that explore the therapeutic benefits of psychedelics, with detailed discussions on dosing and study parameters available in upcoming episodes. Stay tuned for in-depth insights into these transformative studies.In this clip
From this podcast
Huberman Lab
How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks | Huberman Lab Podcast
Related Questions
What has Andrew Huberman said about psychedelics for therapy in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psychedelics in Research?
What has Andrew Huberman said about psychedelics for therapy in the episode Dr. Matthew Johnson: Psychedelics for Treating Mental Disorders | Huberman Lab Podcast #38 and the clip Psychedelics in Research?
What has Andrew Huberman said about psychedelics for therapy in the episode Understanding & Conquering Depression | Huberman Lab Podcast #34 and the clip Psilocybin Experiences?